Contamination of estrogenic compounds disrupts endocrinological and neurological reproductive systems in animals. Neonatal exposure to 17α-ethinyl estradiol (EE) induced an abnormal estrous cycle at postnatal day (PND) 180, but not at PND90. We found that serum level of luteinizing hormone (LH) at the latter half of proestrus in EE-treated rats was lower than in the controls at PND90 when there was no significant difference on estrous cyclicity. Additionally, kiss1 mRNA levels in the anteroventral periventricular nucleus-preoptic area (AVPV/POA) were lower in EE-treated rats than in the controls. The expression of GnRH precursor (GNRH1) mRNA in the AVPV/ POA and that of LH beta subunit (LHb) mRNA in the pituitary were similar in the control-and EE-treated groups. Our results indicated that neonatal exposure to EE leads to reduced expression of kiss1 mRNA in AVPV/POA and LH-surge, which is likely related to the delayed reproductive dysfunction seen in adult female rats. KEY WORDS: 17α-ethinyl estradiol, AVPV/POA, endocrine disruptor, kisspeptin
It has been approximately 20 years since the first World Wildlife Federation (WWF) Wingspread Conference focused on endocrine-disrupting chemicals (EDCs) [11] . EDCs are a broad class of synthetic and natural chemicals, most of which have estrogenic activity [11] . Because these chemicals mimic estrogens that regulate cell fate during embryonic development, exposure to these compounds during the fetal and perinatal periods leads to disruption of endocrinological, neurological and reproductive functions [24] .
In rodents, the sexual differentiation of the brain occurs during the late embryonic and early postnatal periods [14] . In males, androgen secreted from the testis passes the Blood-Brain-Barrier (B-B-B) and reaches the brain, where it is converted to estradiol by the action of p450 aromatase enzymes [10] . The estradiol is essential for the normal sexual differentiation of the male brain. In females, the developing ovary secretes estradiol, but most of the circulating estradiol remains bound to α-fetoprotein and cannot pass the B-B-B [21] . Synthetic estrogenic compounds show the ability to escape from binding to α-fetoprotein. Therefore, exposure to synthetic estrogen compounds during the perinatal period may affect the sexual differentiation of the brain in female rodents.
Kisspeptin, a neuropeptide, plays key roles in determining the timing of puberty and regulation of the estrous cycle by stimulating the Hypothalamic-Pituitary-Gonadal axis (HPG axis) [15] . Kisspeptin is expressed in the anteroventral periventricular nucleus (AVPV) and the arcuate nucleus (ARC) [27] . The number of kisspeptin neurons in the AVPV is substantially higher in females than in males, but their numbers in the ARC are not sexually dimorphic [2] . In female mice, the number of the kisspeptin neurons in the AVPV increases after birth and reaches adult levels at the time of puberty [4] . Because kisspeptin neurons express estrogen receptor α (ERα), it is thought that the increase in the number of kisspeptin neurons is regulated by estradiol secreted from the developing ovary. Conditional deletion of ERα from kisspeptin neurons resulted in an arrest in the pubertal maturation and a failure to acquire normal estrous cycle [20] . Kisspeptin acts through binding to the G protein-coupled receptor GPR54 [15] . This receptor is expressed in GnRH neurons, which are primarily located in the preoptic area (POA) and the ARC [15, 17] . Kisspeptin bound to the receptor in POA induces a GnRH-surge followed by an LHsurge [9] . Kisspeptin bound to its receptor in ARC controls the GnRH and LH pulses [17, 18] . Studies have shown that EDCs cause reproductive dysfunction by affecting the population of kisspeptin neurons [7, 26] . However, the effects of EDCs on kisspeptin neurons remain largely uncharacterized.
In this study, we used 17α-ethinyl estradiol (EE) as model EDC. Previous studies found that a one-time administration of EE (20 µg/kg) at postnatal day 1 (PND1) induced abnormal estrous cycle during PND171-190 [22] . To identify the potential changes in kisspeptin neuron following neonatal exposure to EE, we determined the serum levels of reproductive hormones and analyzed the gene expression in AVPV/ POA, ARC and pituitary at PND90 before the appearance of the abnormal estrous cycle. Here, we show that neonatal EE exposure leads to a reduction in LH-surge and reduced expression of kisspeptin in AVPV/POA.
MATERIALS AND METHODS
Animals: Adult Wistar-Imamichi rats were maintained in an animal room under standard housing conditions with controlled lighting (lights on from 05 hr 00 to 19 hr 00), temperature (25 ± 2°C) and humidity (50 ± 10%). Animals were provided with a rat chow diet (MR-Breeder, Nosan Corporation, Yokohama, Japan) and tap water ad libitum. All animal experiments were performed in compliance with the guidelines of the Institutional Animal Care and Use Committee of Tokyo University of Agriculture and Technology, Japan.
Experimental design: Figure 1 illustrates the experimental design. The sex ratio of the newborn pups in each litter was adjusted to 6:3 (females: males). Female pups were given one of the following neonatal treatments: 1) sesame oil vehicle alone (control group), 2) EE at 20 µg/kg and 3) EE at 200 µg/kg. These treatments were administered within 24 hr of delivery, on PND0, by subcutaneous (S.C.) injection in the nape of the neck. Once vaginal opening occurred, a daily vaginal smear was collected from each rat and the cytological changes were monitored until PND90 (n=16 for each treatment). At approximately PND90, pups were euthanized at 11 hr 00 on the second diestrous day (D), at 11 hr 00 on the proestrous day (PE11), at 17 hr 00 on the proestrous day (PE17) and at 11 hr 00 on the estrous day (E), and the blood and brains were collected (n=4 for each time point). The blood samples were immediately centrifuged (1,500 × g for 15 min at 4°C), and the serum was stored at −20°C until use. The AVPV/POA, the ARC and the pituitary were dissected out from the brain, snap frozen in liquid nitrogen and stored −80°C until further use in RNA extraction. The AVPV/POA and the ARC regions were punched out with the help of a brain punch set (inner diameter of 1.0 mm; Stoeling Corporation., Wheat Lane, Wood Dale, IL, U.S.A. [12] ) from the coronal section of the brain following the coordinates provided in the brain atlas (Paxinos and Watson atlas) [16] .
Hormone assay: Serum concentrations of LH, follicle stimulating hormone (FSH) and prolactin were measured using a rat radioimmunoassay (RIA) kit (NIH, Bethesda, MD, U.S.A.). The iodinated preparations used were rat LH-I-7, rat FSH-I-7 and PRL-I-6. The antisera used were anti-rat LH-S-10, anti-rat FSH-S-11 and PRL-S-9, respectively. The results were expressed in terms of NIDDK rat LH-RP-3, FSH-RP-2 and PRL-RP3. The intra-and inter-assay coefficients of variations were; 2.7% and 22.08%; 7.1% and 22.75%; and 2.46% and 22.20% for LH, FSH and prolactin, respectively.
The serum concentrations of immunoreactive (ir-) inhibin were measured using the rabbit antiserum against bovine inhibin (TNDH-1) and the 125 I-labeled 32-kDa bovine inhibin. Results were expressed as the concentrations of 32-kDa bovine inhibin. The intra-and inter-assay coefficients of variation were 4.77% and 10.30%, respectively.
The serum concentrations of estradiol and testosterone
were measured with the help of a double-antibody RIA system using 125 I-labeled radio ligands. Antisera against estradiol (GDN #244) and testosterone (GDN #250) were provided by Dr. G. D. Niswender (Animal Reproduction and Biotechnology, Colorado State University, Fort Collins, CO, U.S.A.). The intra-and inter-assay coefficients of variation were 5.47% and 18.40%, respectively for estradiol and 2.89% and 21.28%, respectively for testosterone. Quantitative real-time PCR: Total RNA from each sample was extracted using ISOGEN (Nippon Gene, Tokyo, Japan). Complementary DNA (cDNA) was synthesized using PrimeScript reverse transcriptase (TaKaRa Bio, Otsu, Japan) according to the manufacturer's instructions. Oligonucleotide primers were designed using the web-based Primer3 software and are listed in Supplementary Table 1 . All polymerase chain reactions were performed using SYBR Premix Ex Taq™ (TaKaRa Bio). The relative expression level of each target mRNA was determined using the 2 -ΔΔCT method. GAPDH or β-Actin was used as the endogenous control gene.
Statistical analysis: The data are presented as the mean ± SEM of values from three independent experiments. The level of significance was analyzed using one-way analysis of variance (ANOVA), followed by multiple range tests (Graph Pad Prism5). Differences with P<0.05 were considered statistically significant.
RESULTS

Effect of neonatal EE exposure on reproductive parameters:
The changes in body weights are shown in Fig. 2a . The rats in all treatment groups grew normally, and there was no significant difference between the body weights of control and EE-treated groups. The timing of the vaginal opening, which is indicative of puberty, is compared between control and EE-treated groups in Fig. 2b . There was no significant difference between the timing of vaginal opening of the control and EE-treated groups. The time spent in each cycle day at PND90 is shown in Fig. 2c . There was no significant difference in the estrous cycles of all groups at PND90.
Effect of neonatal EE exposure on hormonal changes at PND90: The changes in the serum levels of LH, FSH, inhibin, prolactin, estradiol and testosterone are shown in Fig. 3 . LH-surge was observed at PE17, and the peak levels were reduced in the EE-treated groups compared to control group. In 200 µg/kg EE-treated group, increases of FSH at diestrous and testosterone at PE11 were observed ( Fig. 3b  and 3e ). There were no significant differences in the levels of other hormones between control and EE-treated groups.
Effect of neonatal EE exposure on hypothalamic gene expression at PND90: To examine the potential hypothalamic changes in EE-treated animals, the kisspeptin (kiss1), GPR54, ERα and GNRH1 mRNA levels in the AVPV/POA and the ARC regions were quantified by quantitative realtime PCR. EE treatment reduced the levels of kiss1 mRNA in the AVPV/POA at PE17 (Fig. 4a ). In 200 µg/kg EE-treated group, decrease of GNRH1 mRNA expression at diestrous was observed (Fig. 4d ). There were no significant differences in the mRNA levels of GPR54 and ERα (Fig. 4b and  4c ). Compared to controls, the expression of kiss1 mRNA in the ARC of 200 µg/kg EE-treated group was lower at PE17 (Fig. 5a ). However, there were no significant differences in the mRNA levels of GPR54, ERα and GNRH1 between the ARCs of control and EE-treated groups (Fig. 5b, 5c and 5d ).
Effect of neonatal EE exposure on pituitary gene expression at PND90: The mRNA levels of LHb, FSH beta subunit (FSHb), prolactin (PRL) and GnRH receptor (GNRHR) were determined by quantitative real-time PCR (Fig. 6 ). There were no significant differences in the mRNA expression levels of other genes between the control and the treatment groups.
DISCUSSION
It has been reported that the perinatal exposure to EDCs affects the HPG axis and the brain development related to sexual differentiation. Here, we report EE-induced changes that are potentially related to the delayed reproductive dysfunction. Neonatal EE exposure caused a reduction in the LH-surge level at PND90 when the animals showed a normal estrous cycle. In contrast, these animals showed abnormal estrous cycle at PND180. Reduced kiss1 mRNA expression was also observed in the AVPV/POA of EE-treated animals. It has been reported that in males, no LH-surge occurred and the expression level of kisspeptin in the AVPV/POA was lower in males than females [1, 2] . Neonatal exposure of neonatal females to EE might induce the masculinization of the AVPV/POA region during the sexual differentiation of the brain, which is likely the reason for the reduced kisspeptin gene expression and the low LH-surge at PND90.
In this study, we administered EE (20 and 200 µg/kg) to pups subcutaneously at PND0. The EE has been widely used for oral contraception in women, and the pills contain 50 µg EE, corresponding to 1.0 µg/kg/day. The doses selected in this study were approximately 20-200 times higher than exposure of women. In a previous study, EE (5-50 µg/kg/ day) was administered to dams by oral gavage from gestational day (GD) 7 to PND22 [18] . The authors reported that there were no changes in the kiss1 mRNA expression in the AVPV/POA of pups at PND50 [18] . However, the quantity of EE that reached the pup's circulation is not known. The lower chronic exposure was not sufficient to induce changes in kiss1 gene expression. It is likely that the metabolism of EE in the mother's body, placenta and mammary gland might prevent EE from entering the pup's circulation. Therefore, the timing and method of administration should be prescribed for a comprehensive assessment of the effects of EE. Estrogen regulates kiss1 mRNA expression in kisspeptin neurons [15] . Two distinct subtypes of ER, ERα and ERβ, are known [21] . ERα is predominantly expressed in the uterus, mammary gland, testis, pituitary, liver and kidney, whereas ERβ is primarily expressed in the ovary and prostate [6] . Kisspeptin neurons highly express high levels of ERα, which is higher in females than in males [3, 16, 25] . Estrogen fails to stimulate kiss1 mRNA expression in kisspeptin neurons of the ovariectomized ERα-knockout mice [28] . Thus, ERα mediates estrogen-induced kiss1 gene expression [5] . Our results showed that the expression level of ERα in the AVPV/POA and the ARC of the control-and EE-treated groups was similar. Additionally, serum level of estrogen was unaffected by EE treatment. Taken together, the reduced expression of kiss1 mRNA in the AVPV/POA of EE-treated animals may have been due to a functional impairment of signaling downstream of ER.
The serum LH-surge levels decreased along with the reduction in the level of kiss1 mRNA. Generally, kisspeptin controls LH levels through activating GnRH neuron. GnRHsurge released from the AVPV/POA stimulates pituitary gonadotroph to induce LH-surge without stimulating the transcription. GnRH-pulse generated from the ARC controls basal LH and FSH expression. The AVPV/POA and ARC contained GnRH neurons and we investigated the expression levels of GNRH1 and GPR54 mRNA, however, there were no significant differences in both regions. Furthermore, the expression of LHb and GNRHR mRNA remained unchanged in the pituitary. In 200 µg/kg EE-treated group, the serum FSH showed irregular changes during the estrus cycle, but the expression of FSHb mRNA did not change in the pituitary. It was reported that kisspeptin also elicits FSH secretion and intracerebroventricular administration of kisspeptin peptide stimulated FSH secretion in prepubertal and adult rats [23, 27] . These observations provided the possibility that the decrease in LH-surge and irregular FSH might be linked to the weaken GnRH neuron activity and/or reduced GnRH secretion via down-expressed kisspeptin in the AVPV/POA and ARC of EE-treated animals.
In conclusion, we showed that neonatal exposure to EE leads to reduced kisspeptin expression in the AVPV/ POA and reduced LH-surge, which is likely involved in the delayed reproductive dysfunction in the adult animals. Previous studies have found that when compared to young rats exhibiting normal estrous cycle, middle-aged rats with persistent estrous had low LH-surge and lower percentage of kiss1 mRNA-positive neurons with c-fos immunoreactivity in the AVPV [8, 13, 19, 29] . Since there are some similarities on reproductive phenotypes between neonatal EE exposure animals and middle-aged animals, neonatal EE administration may be useful for generating animal models to investigate the physiological and molecular mechanisms of reproductive aging. Further studies are needed to identify the mechanisms responsible for the suppression of kisspeptin expression following exposure to EE. 
